Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Best Practice & Research. Clinical Haematology
|
June 18, 2019
AML: The future is now or was it yesterday?
Naval Daver, Eytan Stein
Oncology (Williston Park, N.Y.)
|
April 16, 2008
New therapeutic options in gastrointestinal stromal tumors
Eytan Stein, Olivia Aranha, Mark Agulnik
The Journal of Experimental Medicine
|
September 24, 2024
Aberrant pre-mRNA processing in cancer
Jeetayu Biswas, Leora Boussi, Eytan Stein, et al.
Journal of Hematology & Oncology
|
July 29, 2024
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC
Wenbin Xiao, Valentina Nardi, Eytan Stein, et al.
British Journal of Haematology
|
October 15, 2024
Therapeutic strategies targeting aberrant RNA splicing in myeloid malignancies
Leora Boussi, Jeetayu Biswas, Omar Abdel-Wahab, et al.
Journal of Hematology & Oncology
|
August 24, 2019
CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
Michele Stanchina, Alessandro Pastore, Sean Devlin, et al.
Best Practice & Research. Clinical Haematology
|
March 17, 2009
The coagulopathy of acute promyelocytic leukaemia revisited
Eytan Stein, Brandon McMahon, Hau Kwaan, et al.
Mayo Clinic Proceedings
|
December 18, 2023
Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective
Hagop Kantarjian, Amer M Zeidan, Amir T Fathi, et al.
The Journal of Biological Chemistry
|
August 22, 2002
Radicicol-sensitive peptide binding to the N-terminal portion of GRP94
Shawn Vogen, Tali Gidalevitz, Chhanda Biswas, et al.
Hematology/Oncology Clinics of North America
|
November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?
Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Best Practice & Research. Clinical Haematology
|
June 18, 2019
AML: The future is now or was it yesterday?
Naval Daver, Eytan Stein
Oncology (Williston Park, N.Y.)
|
April 16, 2008
New therapeutic options in gastrointestinal stromal tumors
Eytan Stein, Olivia Aranha, Mark Agulnik
The Journal of Experimental Medicine
|
September 24, 2024
Aberrant pre-mRNA processing in cancer
Jeetayu Biswas, Leora Boussi, Eytan Stein, et al.
Journal of Hematology & Oncology
|
July 29, 2024
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC
Wenbin Xiao, Valentina Nardi, Eytan Stein, et al.
British Journal of Haematology
|
October 15, 2024
Therapeutic strategies targeting aberrant RNA splicing in myeloid malignancies
Leora Boussi, Jeetayu Biswas, Omar Abdel-Wahab, et al.
Journal of Hematology & Oncology
|
August 24, 2019
CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
Michele Stanchina, Alessandro Pastore, Sean Devlin, et al.
Best Practice & Research. Clinical Haematology
|
March 17, 2009
The coagulopathy of acute promyelocytic leukaemia revisited
Eytan Stein, Brandon McMahon, Hau Kwaan, et al.
Mayo Clinic Proceedings
|
December 18, 2023
Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective
Hagop Kantarjian, Amer M Zeidan, Amir T Fathi, et al.
The Journal of Biological Chemistry
|
August 22, 2002
Radicicol-sensitive peptide binding to the N-terminal portion of GRP94
Shawn Vogen, Tali Gidalevitz, Chhanda Biswas, et al.
Hematology/Oncology Clinics of North America
|
November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?
Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Page
of 3